Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor

Cerebral Morbidity After Radiation Therapy for Brain Tumors

NCT04292353 ·Status: UNKNOWN

Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:

NCT06036706 ·Status: RECRUITING ·Phase: NA

FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy

NCT03370926 ·Status: UNKNOWN

Cognitive Function After Radiation Therapy for Brain Tumours

NCT04118426 ·Status: COMPLETED

Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection

NCT02887651 ·Status: UNKNOWN ·Phase: NA

Stereotactic Radiotherapy Management of Brain Metastases: the Value of a Longitudinal Multimodal Approach (POSTPONE)

NCT06029140 ·Status: UNKNOWN

Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas

NCT06180226 ·Status: COMPLETED

Multicenter Retrospective Study on Patients Treated with Stereotactic Radiosurgery/Radiotherapy for Single Brain Lesions: Evaluation of Treatment Efficacy and Safety, Also Through Radiomic Analysis Methods.

NCT06869460 ·Status: ACTIVE_NOT_RECRUITING

Neurococognitive and Functioal Assessment of Patients With Brain Metastases

NCT01861405 ·Status: UNKNOWN

Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study

NCT05895344 ·Status: RECRUITING ·Phase: NA

Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors

NCT03394716 ·Status: TERMINATED

Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas

NCT04766632 ·Status: COMPLETED ·Phase: NA

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

NCT05692635 ·Status: RECRUITING ·Phase: PHASE2

Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy

NCT01212237 ·Status: WITHDRAWN

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.

NCT04461002 ·Status: COMPLETED

Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients

NCT03903419 ·Status: UNKNOWN ·Phase: NA

Proton/Photon Rt - Benign Meningiomas(P92-13)

NCT02947984 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain Metastasis

NCT04358666 ·Status: UNKNOWN ·Phase: NA

Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients

NCT01579253 ·Status: UNKNOWN

Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

NCT01227954 ·Status: COMPLETED ·Phase: PHASE2

Blood Flow MRI for Monitoring Brain Tumors

NCT01538264 ·Status: ACTIVE_NOT_RECRUITING

Cerebral Bases Bodily Representations

NCT02876016 ·Status: UNKNOWN ·Phase: NA

Stereotactic Radiotherapy of the Resection Cavity of Brain Metastases vs. Post-operative Whole-brain Radiotherapy

NCT03285932 ·Status: COMPLETED ·Phase: PHASE2

Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost

NCT04006561 ·Status: RECRUITING

Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.

NCT07119294 ·Status: RECRUITING ·Phase: NA